Levetiracetam Ucb

Levetiracetam, the active ingredient in Levetiracetam Ucb, is an anticonvulsant presented as an injectable solution for intravenous use. It treats partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Ucb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication indicated for several seizure types within the epilepsy disease spectrum. - Partial‑onset seizures: provides seizure control by decreasing the frequency of focal seizures in individuals diagnosed with epilepsy. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in both adult and pediatric patients with generalized seizure disorders. - Myoclonic seizures: reduces the occurrence of sudden muscle jerks in patients with juvenile myoclonic epilepsy or other myoclonic seizure conditions.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Headache - Irritability - Nausea - Nasal congestion

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Mood changes including depression or suicidal thoughts - Hematologic abnormalities such as neutropenia or thrombocytopenia - Skin rash with blistering

When using Levetiracetam, clinicians should consider several precautionary measures to ensure safe therapy. - Renal impairment: adjust dose based on creatinine clearance and monitor renal function. - Psychiatric history: observe for new or worsening depression, anxiety, or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy: limited data; weigh potential benefits against unknown fetal risk. - Lactation: assess infant exposure through breast milk and consider alternatives. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations, decreasing seizure control. - Phenobarbital: can lower levetiracetam levels, potentially leading to breakthrough seizures.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam exposure, requiring monitoring for side effects. - Sedative agents (benzodiazepines, opioids): additive CNS depression may enhance drowsiness. - Oral contraceptives: levetiracetam may slightly reduce hormonal contraceptive effectiveness; advise additional contraceptive measures.